The Overuse of "Stat" in Imaging Centers

Article

Once upon a time, when I worked primarily in hospitals, “stat” referred to emergencies, or at least something with real urgency (such as the patient is being cleared to have surgery tomorrow morning, etc.). After leaving the inpatient (and ER) world for outpatient imaging centers, I encountered some other uses of “stat.”

Stat: (from Latin: statim)- Without delay; immediately.

Once upon a time, when I worked primarily in hospitals, “stat” referred to emergencies, or at least something with real urgency (such as the patient is being cleared to have surgery tomorrow morning, etc.). After leaving the inpatient (and ER) world for outpatient imaging centers, I encountered some other uses of “stat:”

* The patient is a VIP (or directly related to one).

* The patient is about to go on a vacation (or other travel), and wants to know results before departing.

* The patient's referring clinician is being courted so she or he will send more referrals, and every patient sent by said referrer gets priority over patients from other referrers.

* The patient's insurance requires a quick turnaround time, so patients on that plan get priority over other patients.

The variety of non-emergent “stat”s seems to grow, year by year. I still see "real" stat studies (we sometimes call them “stat stats”) from time to time. We sometimes joke about having color-coded stat stickers for patients’ charts so we can prioritize them - red emergency stats would get read before the orange VIPs, who would get read before the pink VIP referrers, etc. It seems inevitable that, sooner or later, non-stat studies will become the minority.

I've always found it rather slimy that some patients get kicked to the back of the line, just because they were unfortunate enough to get referred by the wrong clinician. It reminds me of George Orwell’s “Animal Farm:” “All animals are equal but some animals are more equal than others.”

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.